Highlights Include:

Time: 2:00 pm
day: Pre-Conference Workshop Day


  • Exploring early detection and identification of pulmonary fibrosis
  • Comparing inflammatory and fibrotic ILD data
  • Highlighting the role of immune cells in ILD and fibrosis
  • Unlocking IPF as the key to succeed in other types of ILD by capturing the translatability of therapeutics
  • Investigating ILD biomarkers to understand trial populations
  • Identifying endpoints which are likely to predict clinical success
  • Considering when resolution of inflammation goes wrong
  • Understanding the RA-ILD biomarkers, genetics, proteomics, and therapeutics currently available
  • Cultivating effective therapeutics that reflect the unique patient populations of interstitial lung disease